Skip to content
The Policy VaultThe Policy Vault

Focalin XR — CareFirst (Caremark)

Attention Deficit Disorder (ADD)

Initial criteria

  • Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD) has been appropriately documented (e.g., evaluated by a complete clinical assessment, using DSM-5, standardized rating scales, interviews/questionnaires).
  • If patient age ≤ 5 years, patient continues to have ADHD/ADD symptoms despite participating in evidence-based behavioral therapy (e.g., parent training in behavior management (PTBM), behavioral classroom interventions).

Reauthorization criteria

  • Patient achieved or maintained improvement in signs and symptoms of ADHD/ADD from baseline.
  • Patient’s need for continued therapy has been assessed within the previous year.